Issue 46

January - February 2012

Article of the week:

e-Grand Round

Optimising dose-dense regimens for early breast cancer

Clifford Hudis takes a look at how dose-dense regimens, intended to increase efficacy by decreasing the time between doses, work and effect toxicity in early breast cancer, especially where targeted agents are added. Read More..

Every Friday, a new Article of the Week is posted on our website.
Please click here if you would like to receive our free weekly e-newsletter which highlights the weekly article.

 

RECENT COMMENTS

Cindy: I'm not a medical professional. My mother has been diagnosed with CUP - and was treated several year [...]   »Read more

Rajesh Kumar: +919681303310.   »Read more

Rajesh Kumar: Please write your comment here   »Read more

christian: Is gabapentin has been proposed to treat peripheric neuropathy induced by chemotherapy. At low dosa [...]   »Read more

Ricardo Teixeira (Aspirin for cancer prevention): We prescribe Aspirin in order to prevent several Cancers and we think that a short period it is esse [...]   »Read more

CancerWorld invites you to visit:

 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.